THE IMPORTANCE OF COSMETOVIGILANCE AND THE INVOLVEMENT OF COSMETOLOGISTS IN ENSURING PHARMACOSAFETY
DOI:
https://doi.org/10.52340/jecm.2023.04.44Ключевые слова:
pharmacovigilance, cosmetovigilance, pharmacosafetyАннотация
The term “pharmacovigilance” defines the activities related to the collection, detection, assessment, monitoring, and prevention of adverse reactions occurring with the use medications. Recently, the spectrum of “-vigilance” has broadened to include safety of herbal products and cosmetic products as well. “Cosmetovigilance” was introduced as a new term used for defining surveillance carried out by industry to address the safety of products used in aesthetic medicine.
In order of speed up the share of information, people involved in healthcare system and beauty industry should be maximally mobilized and motivated to immediately report even the slightest side effect to the authorized body.
The conducted research revealed the willingness of medical aestheticians to actively engage in pharmaco- and cosmetic- vigilance. However, at the same time, there is a noticeable lack of information, and in some cases non-existence, on how to monitor and report adverse effects. Increasing the spread of the quality of information, among the specialists, significantly depends on the activity of the state regulatory system.
Скачивания
Библиографические ссылки
World Health Organization. Safety Monitoring of Medicinal Products: Reporting System for the General Public. Geneva, Switzerland: World Health Organization; 2012.
Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?). Available from:https://www.fda.gov/cosmetics/guidanceregulation/lawsregulations/ucm074201.htm.
Toklu H. Pharmacovigilance of herbal medicine: Herbavigilance. Adv Pharmacoepidemiol Drug Safty 2016; 5:208.
Vigan M, Castelain F. Cosmetovigilance: Definition, regulation and use “in practice.” Eur J Dermatol 2014;24:643-9.
Kornfeld-Lecanu S, Zajaczkowski F, et.al. Vigilance in industry: cosmetics and household cleaning products. Balance sheet of case report from 2005 to 2007. Clin Exp Dermatol 2010; 35:874-80.
Zweers PG, Gilmour NJ, et al. Causality methods in cosmetovigilance: Comparison of Colipa and PLM versus global introspection. Regul Toxicol Pharmacol 2012;63:409-17.
Bons B, Audebert F, Bitaudeau C, Cachin N, Colson L, Farr C, et al. Assessment of undesirable events in cosmetic market surveillance: Background, description and use of a causality assessment method in cosmetovigilance. Regul Toxicol Pharmacol. 2010;58:349-53.
Annex 1: Causality Assessment of Undesirable Effects Caused By Cosmetic Products in `SUE Reporting Guidelines`. European Comission, 2013. Available from: https://ec.europa.eu/docsroom/documents/13251/attachments/1/translations/en/renditions/native.
Sautebin L. A cosmetovigilance survey in Europe. Pharmacol Res. 2007;55:455-60.
Toklu HZ, Mensah E. Why do we need pharmacists in pharmacovigilance systems? Online J Public Health Inform. 2016;8:193.